Purpose: Epithelial to mesenchymal transitions are vital for tumor growth and metastasis.Several inducers of epithelial to mesenchymal transition are transcription factors that repress E-cadherin expression, such as Snail, Slug, and Twist. In this study, we aimed to examine the expression of these transcription factors in pancreatic cancer. Experimental Design: The expression of Snail, Slug, and Twist was detected by immunohistochemistry in tissue samples from patients with pancreatic ductal adenocarcinoma. Five human pancreatic cancer cell lines (AsPC-1, Capan-1, HPAF-2, MiaPaCa-2, and Panc-1) were analyzed by reverse transcription-PCR, real-time PCR, and Western blotting. An orthotopic nude mouse model of pancreatic cancer was applied for in vivo experiments. Results: Seventy-eight percent of human pancreatic cancer tissues showed an expression of Snail, and 50% of the patients displayed positive expression of Slug. Twist showed no or only weak expression. Snail expression was higher in undifferentiated cancer cell lines (MiaPaCa-2 and Panc-1) than in more differentiated cell lines (Capan-1, HPAF-2, AsPC-1). Expression of Slug was detected in all cell lines with different intensities. Twist was not expressed. After exposure to hypoxia, theTwist gene was activated in all five pancreatic cancer cell lines. Conclusions:The transcription factors Snail and Slug are expressed in pancreatic cancer but not in normal tissue, suggesting a role in the progression of human pancreatic tumors.Twist, activated by hypoxia, may play an important role in the invasive behavior of pancreatic tumors.Pancreatic cancer is the fifth leading cause of cancer-related death in industrial western countries. It is an aggressive disease with <5% survival after 5 years (1, 2). This is largely attributable to late clinical presentation and limitations in diagnostic methods. More than 80% of patients are diagnosed with pancreatic cancer at a locally advanced or metastatic stage, which excludes a curative surgical resection (3). The response to conventional therapies, such as radiotherapy and chemotherapy, is poor and has little effect on the natural progress of this malignancy (4). Understanding the molecular biology of pancreatic cancer and metastasis may provide insight for the development of novel tumor markers or new therapeutic strategies.Epithelial to mesenchymal transition (EMT) is a key step during embryonic morphogenesis and is involved in the progression of primary tumors toward metastasis (5). During EMT, cells undergo a developmental switch from a polarized, epithelial phenotype to a highly motile fibroblastoid or mesenchymal phenotype (6). Tumor cells begin to grow invasive, enter into systemic circulation (''intravasation''), move from the circulatory system into a new host tissue (''extravasation''), and proliferate and grow to a secondary tumor. The cell adhesion molecules E-cadherin and N-cadherin, members of the classic cadherin family, are regarded as inducers of EMT (7,8). E-cadherin is required for the formation o...